Results 11 to 20 of about 11,864,187 (263)

Liver diseases: epidemiology, causes, trends and predictions

open access: yesSignal Transduction and Targeted Therapy
As a highly complex organ with digestive, endocrine, and immune-regulatory functions, the liver is pivotal in maintaining physiological homeostasis through its roles in metabolism, detoxification, and immune response.
Jia Xiao, Jinhang Gao, Haiyuan Shen
exaly   +2 more sources

Regulation and functional roles of chemokines in liver diseases

open access: yesNature Reviews Gastroenterology and Hepatology, 2021
Inflammation is a major contributor to the pathogenesis of almost all liver diseases. Low-molecular-weight proteins called chemokines are the main drivers of liver infiltration by immune cells such as macrophages, neutrophils and others during an ...
Sheng Cao   +2 more
exaly   +2 more sources

Gut-Liver Axis, Gut Microbiota, and Its Modulation in the Management of Liver Diseases: A Review of the Literature

open access: yesInternational Journal of Molecular Sciences, 2019
The rapid scientific interest in gut microbiota (GM) has coincided with a global increase in the prevalence of infectious and non-infectivous liver diseases.
Miloš Korac   +2 more
exaly   +2 more sources

The Role of Oxidative Stress and Antioxidants in Liver Diseases

open access: yesInternational Journal of Molecular Sciences, 2015
A complex antioxidant system has been developed in mammals to relieve oxidative stress. However, excessive reactive species derived from oxygen and nitrogen may still lead to oxidative damage to tissue and organs.
, Yibin Feng, Ning Wang
exaly   +2 more sources

Malnutrition, Frailty, and Sarcopenia in Patients With Cirrhosis: 2021 Practice Guidance by the American Association for the Study of Liver Diseases

open access: yesHepatology, 2021
This is the first American Association for the Study of Liver Diseases (AASLD) Practice Guidance on the management of malnutrition, frailty, and sarcopenia in patients with cirrhosis.
J. Lai   +6 more
semanticscholar   +1 more source

Metabolic dysfunction-associated steatotic liver disease: Update and impact of new nomenclature on the American Association for the Study of Liver Diseases practice guidance on nonalcoholic fatty liver disease.

open access: yesHepatology, 2023
This commentary discusses how clinicians and various stakeholders can utilize the recently published American Association for the Study of Liver Diseases nonalcoholic fatty liver disease (AASLD NAFLD) Practice Guidance in light of the change in the ...
F. Kanwal   +3 more
semanticscholar   +1 more source

Mitochondrial alterations in fatty liver diseases.

open access: yesJournal of Hepatology, 2022
Fatty liver diseases increasingly arise from common metabolic diseases, but also from xenobiotics and excessive alcohol use. Despite different etiology, they share several similarities regarding their toxic effects on hepatic mitochondrial functionality ...
B. Fromenty, M. Roden
semanticscholar   +1 more source

Characteristics and Clinical Significance of Intestinal Microbiota in Patients with Chronic Hepatitis B Cirrhosis and Type 2 Diabetes Mellitus

open access: yesJournal of Diabetes Research, 2022
Background. Chronic hepatitis B cirrhosis is often accompanied by glucose metabolism disorder, and intestinal microbiota was closely related to both cirrhosis and diabetes.
Xiu Sun   +4 more
doaj   +1 more source

Mitochondrial dysfunction: A promising therapeutic target for liver diseases

open access: yesGenes and Diseases, 2023
The liver is an important metabolic and detoxification organ and hence demands a large amount of energy, which is mainly produced by the mitochondria.
Ping Chen   +6 more
semanticscholar   +1 more source

Fenofibrate in primary sclerosing cholangitis; a randomized, double‐blind, placebo‐controlled trial

open access: yesPharmacology Research & Perspectives, 2022
Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease with no medical treatment proven to improve survival and postpone liver transplantation. Previous studies have shown the effectiveness of fibrates in primary biliary cholangitis.
Behzad Hatami   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy